Zhejiang Tianyu Pharmaceutical (300702.SZ)Pregabalin Capsules Obtained Drug Registration Certificate
Tianyu Group (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode...
Zhejiang Tianyu Pharmaceutical (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode Pharmaceutical") recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Prugabalin Capsules.
The announcement stated that Prugabalin Capsules are used to treat postherpetic neuralgia and fibromyalgia, a medication for postherpetic neuralgia.
Related Articles
US Stock Market Move | Q3 revenue beats expectations; Southeast Asian e-commerce giant Sea (SE.US) rises nearly 8% in early trading
Bernstein: Long-term power supply agreements continue to increase, Constellation Energy's (CEG.US) future revenue outlook is clearer, "Outperform" rating maintained.
A-share Evening Highlights | US CPI Exceeds Expectations! Gold Falls Below $4,040
US Stock Market Move | Q3 revenue beats expectations; Southeast Asian e-commerce giant Sea (SE.US) rises nearly 8% in early trading
Bernstein: Long-term power supply agreements continue to increase, Constellation Energy's (CEG.US) future revenue outlook is clearer, "Outperform" rating maintained.
A-share Evening Highlights | US CPI Exceeds Expectations! Gold Falls Below $4,040
